MUC3B Antibody (C-term E881) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9H195 |
---|---|
Clone Names | 80722066 |
Other Names | Mucin-3B, MUC-3B, Intestinal mucin-3B, MUC3B |
---|---|
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | MUC3B (HGNC:13384) |
---|---|
Function | Major glycoprotein component of a variety of mucus gels. Thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces (By similarity). |
Cellular Location | Membrane; Single-pass membrane protein |
Tissue Location | Fetal and adult small intestine and fetal and adult colon. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The protein encoded by this gene is a member of the S100family of proteins containing 2 EF-hand calcium-binding motifs.S100 proteins are localized in the cytoplasm and/or nucleus of awide range of cells, and involved in the regulation of a number ofcellular processes such as cell cycle progression anddifferentiation. S100 genes include at least 13 members which arelocated as a cluster on chromosome 1q21. This protein may functionin stimulation of Ca2+-induced Ca2+ release, inhibition ofmicrotubule assembly, and inhibition of protein kinase C-mediatedphosphorylation. Reduced expression of this protein has beenimplicated in cardiomyopathies.
References
Marlatt, N.M., et al. Protein Expr. Purif. 73(1):58-64(2010)van Dieck, J., et al. FEBS Lett. 584(15):3269-3274(2010)Sviatoha, V., et al. Melanoma Res. 20(2):118-125(2010)DeRycke, M.S., et al. Am. J. Clin. Pathol. 132(6):846-856(2009)Yusenko, M.V., et al. Int. J. Biol. Sci. 5(6):517-527(2009)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.